There have been 50 recent insider transactions recorded for Femasys Inc. (FEMY), including 40 buys and 1 sell. Total insider buying was valued at $1.52M and total insider selling at $6.25M.
Notable insiders with recent activity include Canning John Charles, Elefant Dov, Lee-sepsick Kathy. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — FEMY
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-30 |
Canning John Charles |
Chief Operating Officer |
Unknown |
- |
- |
- |
30,000 |
| 2026-03-30 |
Canning John Charles |
Chief Operating Officer |
RSU Award |
150,000 |
$0.38 |
$57K |
150,000 |
| 2026-03-19 |
Elefant Dov |
Chief Financial Officer |
RSU Award |
34,122 |
$0.58 |
$19.79K |
34,122 |
| 2026-03-19 |
Lee-sepsick Kathy |
Chief Executive Officer |
RSU Award |
68,244 |
$0.58 |
$39.58K |
68,244 |
| 2026-03-19 |
Larsen Charles |
Director |
RSU Award |
34,122 |
$0.58 |
$19.79K |
34,122 |
| 2026-03-19 |
Eichenbaum Kenneth D. |
Director |
RSU Award |
102,366 |
$0.58 |
$59.37K |
102,366 |
| 2026-03-18 |
Eichenbaum Kenneth D. |
Director |
RSU Award |
35,200 |
$0.60 |
$21.12K |
35,200 |
| 2026-03-18 |
Eichenbaum Kenneth D. |
Director |
Unknown |
- |
- |
- |
25,010 |
| 2026-03-17 |
Pharmacyte Biotech, Inc. |
10 Percent Owner |
Unknown |
- |
- |
- |
- |
| 2026-03-17 |
Silverman Joshua |
Director |
Unknown |
- |
- |
- |
- |
| 2026-02-19 |
Elefant Dov |
Chief Financial Officer |
RSU Award |
169,000 |
- |
- |
169,000 |
| 2026-02-19 |
Lee-sepsick Kathy |
Chief Executive Officer |
RSU Award |
282,000 |
- |
- |
282,000 |
| 2026-02-02 |
Sipos Jeremy Alexander |
Chief Technology Officer |
RSU Award |
80,000 |
- |
- |
80,000 |
| 2025-12-16 |
Sipos Jeremy Alexander |
Chief Technology Officer |
Unknown |
3,334 |
$6.12 |
$20.4K |
- |
| 2025-11-07 |
Elefant Dov |
Chief Financial Officer |
Discretionary Buy |
- |
$0.73 |
- |
- |
| 2025-11-07 |
Larsen Charles |
Director |
Discretionary Buy |
- |
$0.73 |
- |
- |
| 2025-11-07 |
Lee-sepsick Kathy |
Chief Executive Officer |
Discretionary Buy |
- |
$0.73 |
- |
- |
| 2025-11-07 |
Eichenbaum Kenneth D. |
Director |
Unknown |
102,366 |
$1.10 |
$112.6K |
- |
| 2025-08-27 |
Elefant Dov |
Chief Financial Officer |
Discretionary Buy |
38,828 |
$0.52 |
$20K |
38,828 |
| 2025-08-27 |
Lee-sepsick Kathy |
Chief Executive Officer |
Discretionary Buy |
48,535 |
$0.52 |
$25K |
48,535 |
| 2025-06-25 |
Silverman Joshua |
Director |
RSU Award |
17,600 |
$0.98 |
$17.25K |
17,600 |
| 2025-06-25 |
Uzialko Edward R |
Director |
RSU Award |
17,600 |
$0.98 |
$17.25K |
17,600 |
| 2025-06-25 |
Larsen Charles |
Director |
RSU Award |
17,600 |
$0.98 |
$17.25K |
17,600 |
| 2025-06-25 |
Milnes Alistair |
Director |
RSU Award |
17,600 |
$0.98 |
$17.25K |
17,600 |
| 2025-06-23 |
Nicholas Kelley Stinson |
Chief Commercial Officer |
Unknown |
- |
- |
- |
45 |
| 2025-06-23 |
Nicholas Kelley Stinson |
Chief Commercial Officer |
RSU Award |
100,000 |
$0.90 |
$90K |
100,000 |
| 2025-06-02 |
Elefant Dov |
Chief Financial Officer |
Discretionary Buy |
19,608 |
$1.02 |
$20K |
19,608 |
| 2025-06-02 |
Lee-sepsick Kathy |
Chief Executive Officer |
Discretionary Buy |
34,314 |
$1.02 |
$35K |
312,092 |
| 2025-06-02 |
Currie Daniel Scott |
Chief Operating Officer |
Discretionary Buy |
19,608 |
$1.02 |
$20K |
86,275 |
| 2025-06-02 |
Larsen Charles |
Director |
Discretionary Buy |
24,510 |
$1.02 |
$25K |
56 |
| 2025-01-29 |
Lee-sepsick Kathy |
Chief Executive Officer |
RSU Award |
59,849 |
$1.17 |
$70.02K |
59,849 |
| 2025-01-28 |
Elefant Dov |
Chief Financial Officer |
RSU Award |
72,045 |
$1.05 |
$75.65K |
72,045 |
| 2025-01-28 |
Currie Daniel Scott |
Chief Operating Officer |
RSU Award |
29,184 |
$1.05 |
$30.64K |
29,184 |
| 2025-01-28 |
Thomas Christine E |
Chief Reg & Clinical Officer |
RSU Award |
23,600 |
$1.05 |
$24.78K |
23,600 |
| 2024-07-12 |
Silverman Joshua |
Director |
RSU Award |
17,600 |
$1.14 |
$20.06K |
17,600 |
| 2024-07-12 |
Uzialko Edward R |
Director |
RSU Award |
17,600 |
$1.14 |
$20.06K |
17,600 |
| 2024-07-12 |
Larsen Charles |
Director |
RSU Award |
17,600 |
$1.14 |
$20.06K |
17,600 |
| 2024-07-12 |
Milnes Alistair |
Director |
RSU Award |
17,600 |
$1.14 |
$20.06K |
17,600 |
| 2024-02-12 |
Spector Richard D. |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-02-12 |
Spector Richard D. |
Chief Commercial Officer |
RSU Award |
100,000 |
$1.10 |
$110K |
100,000 |
| 2024-02-01 |
Elefant Dov |
Chief Financial Officer |
RSU Award |
84,000 |
$0.80 |
$67.2K |
84,000 |
| 2024-02-01 |
Lee-sepsick Kathy |
Chief Executive Officer |
RSU Award |
204,900 |
$0.80 |
$163.92K |
204,900 |
| 2024-02-01 |
Currie Daniel Scott |
Chief Operating Officer |
RSU Award |
61,900 |
$0.80 |
$49.52K |
61,900 |
| 2024-02-01 |
Thomas Christine E |
SVP, Regulatory & Clinical |
RSU Award |
32,600 |
$0.80 |
$26.08K |
32,600 |
| 2023-11-21 |
Silverman Joshua |
Officer |
Unknown |
- |
- |
- |
- |
| 2023-11-21 |
Silverman Joshua |
Director |
RSU Award |
17,000 |
$0.90 |
$15.3K |
17,000 |
| 2023-11-21 |
Pharmacyte Biotech, Inc. |
10 Percent Owner |
Disposition |
4,237,288 |
$1.48 |
$6.25M |
- |
| 2023-10-10 |
Thomas Christine E |
SVP, Regulatory & Clinical |
RSU Award |
60,000 |
$1.76 |
$105.6K |
60,000 |
| 2023-07-03 |
Elefant Dov |
Chief Financial Officer |
RSU Award |
105,200 |
$0.49 |
$51.55K |
105,200 |
| 2023-07-03 |
Lee-sepsick Kathy |
Chief Executive Officer |
RSU Award |
270,400 |
$0.49 |
$132.5K |
270,400 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
